Lamei Pharmaceuticals: Subscribed capital of RMB 5 million, accounting for 3.33% of the subscribed contribution.

2026-03-28 11:38:22

Lai Mei Pharmaceuticals announced that recently, the company signed the Partnership Agreement of Guangzhou Shengquan Baijie Venture Capital Fund Partnership (Limited Partnership) with Xi’an Wo Jie Private Equity Fund Management Co., Ltd. and others, with the intention of jointly establishing Guangzhou Shengquan Baijie Venture Capital Fund Partnership (Limited Partnership). The total fundraising amount for the partnership is 150 million yuan, of which the company, as a limited partner, has committed to contribute 5 million yuan of its own funds, accounting for 3.33% of the total.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes